A new study confirms a link between Novo Nordisk’s Ozempic and an increased risk of NAION, a rare, irreversible form of vision loss. Research indicates Ozempic users are over twice as likely to develop NAION compared to those on other diabetes medications. While the risk remains low, with 1.
Samachar Patra Pro: News Everywhere, Always Accurate – Get the World's Major News, Rapidly!